Gentium Begins Trading on NASDAQ; New Ticker Symbol: GENT
May 16 2006 - 8:00AM
Business Wire
Gentium S.p.A. (NASDAQ:GENT)(AMEX:GNT) (the Company) today
announced that its American Depository Shares (ADSs) will be listed
and begin trading today on the NASDAQ National Market System under
the symbol: GENT. Gentium ADSs will no longer be listed on the
American Stock Exchange. The NASDAQ Stock Market is the largest
electronic screen-based equity securities market in the United
States with approximately 3,200 listed companies. It is a
highly-regulated electronic securities market comprised of
competing market makers whose trading is supported by a
communications network linking them to quotation dissemination,
trade reporting, and order execution systems. The NASDAQ Stock
Market, which includes the NASDAQ NMS and the NASDAQ Capital
Market, is operated by the NASDAQ Stock Market, Inc. About Gentium
Gentium S.p.A. is a biopharmaceutical company located in Villa
Guardia (Como), Italy that is focused on the research, discovery
and development of drugs derived from DNA extracted from natural
sources, and drugs that are synthetic derivatives, to treat and
prevent a variety of vascular diseases and conditions related to
cancer and cancer treatments. Defibrotide, the Company's lead
product candidate in the U.S., is an investigational drug that has
been granted Orphan Drug status by the U.S. FDA to treat Severe VOD
and Fast Track designation for the treatment of Severe VOD in
recipients of stem cell transplants. Cautionary Note Regarding
Forward-Looking Statements This press release contains
"forward-looking statements." In some cases, you can identify these
statements by forward-looking words such as "may," "might," "will,"
"should," "expect," "plan," "anticipate," "believe," "estimate,"
"predict," "potential" or "continue," the negative of these terms
and other comparable terminology. These statements are not
historical facts but instead represent the Company's belief
regarding future results, many of which, by their nature, are
inherently uncertain and outside the Company's control. It is
possible that actual results may differ, possibly materially, from
those anticipated in these forward-looking statements. For a
discussion of some of the risks and important factors that could
affect future results, see the discussion in our Prospectus filed
with the Securities and Exchange Commission under Rule 424(b)(5)
under the caption "Risk Factors." Source: Gentium
Gentium Spa (AMEX:GNT)
Historical Stock Chart
From May 2024 to Jun 2024
Gentium Spa (AMEX:GNT)
Historical Stock Chart
From Jun 2023 to Jun 2024